COPD trials in Peru

3 of 3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  Where

  Lima

  Age

  40 years and over

  People

  987 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07082738
• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  Where

  Callao, Cusco, Lima, Piura

  Age

  40 years to 80 years

  People

  990 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06878261 · EU 2024-517457-27-00
• Phase 3Taking people
  A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  Where

  El Agustino, Lima, Piura

  Age

  40 years to 80 years

  People

  5,250 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06283966 · EU 2023-507407-59-00